NasdaqCM - Nasdaq Real Time Price • USD
Phio Pharmaceuticals Corp. (PHIO)
As of 2:18 PM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-10,749.0000
-10,749.0000
-12,129.0000
-11,858.0000
-8,802.0000
Investing Cash Flow
-5.0000
-5.0000
-121.0000
-51.0000
-19.0000
Financing Cash Flow
7,413.0000
7,413.0000
-26.0000
21,722.0000
16,131.0000
End Cash Position
8,490.0000
8,490.0000
11,831.0000
24,107.0000
14,294.0000
Interest Paid Supplemental Data
--
--
--
8.0000
6.0000
Capital Expenditure
-5.0000
-5.0000
-121.0000
-51.0000
-19.0000
Issuance of Capital Stock
7,452.0000
7,452.0000
2.0000
19,577.0000
12,088.0000
Issuance of Debt
--
--
--
--
231.0000
Repayment of Debt
--
--
--
--
-27.0000
Repurchase of Capital Stock
-13.0000
-13.0000
--
--
-15.0000
Free Cash Flow
-10,754.0000
-10,754.0000
-12,250.0000
-11,909.0000
-8,821.0000
12/31/2020 - 5/10/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NKGN NKGen Biotech, Inc.
1.6600
-16.19%
PCSA Processa Pharmaceuticals, Inc.
2.2700
-6.72%
ADIL Adial Pharmaceuticals, Inc.
1.6600
-4.05%
ABVC ABVC BioPharma, Inc.
1.4600
-8.25%
ASLN ASLAN Pharmaceuticals Limited
0.4200
-6.25%
MLEC Moolec Science SA
1.4900
+4.93%
HOOK HOOKIPA Pharma Inc.
0.8824
+9.47%
SILO Silo Pharma, Inc.
1.9300
+1.58%
PALI Palisade Bio, Inc.
6.25
+0.32%
CYTO Altamira Therapeutics Ltd.
1.7300
+8.12%